Use of the COPD case-finding tool, CAPTURE, in US primary care practice demonstrated ability to provide critical in-study information to help guide protocol adjustment based on unforeseen events and to clearly outline COPD diagnostic processes.
Use of vasoactive intestinal peptide to treat critical COVID-19 respiratory failure in patients with comorbidities has shown promise.
The DS-Cav1 vaccination for respiratory syncytial virus (RSV) has been shown to be safe and well tolerated.
Investigators sought to confirm whether obstructive sleep apnea syndrome might be a susceptibility factor for the development of COVID-19 encephalopathy.
Approximately one-sixth of patients with obstructive sleep apnea (OSA) have demonstrated symptoms of dysphagia.
High D-dimer levels were associated with lung parenchymal abnormalities on computed tomography (CT) scans in a cohort of individuals from 6 US communities.
Airway symptoms may develop in menopausal women with no prior history of asthma following the initiation of hormone replacement therapy.
Greater pericardial adipose tissue and abdominal visceral adipose tissue has been linked to interstitial lung abnormalities, increased high attenuation areas, and decreased forced vital capacity.
Scare utilization of guideline-recommended risk stratification tools has been noted in computed tomography pulmonary angiography in the emergency department.
Interventions designed to enhance physical activity in urban children with asthma need to address both the management of asthma and physical activity.
